LEWIS JOEL bought GALT
December 17, 2025 · Form 4 insider transaction
LEWIS JOEL bought 7,829 shares of Galectin Therapeutics Inc. at $2.86 per share, a transaction worth $22.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,829
Price
$2.86
Total value
$22.4K
InsiderLEWIS JOEL
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 17, 2025
Filing dateDecember 19, 2025
Shares owned after840,421
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on April 17, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on August 14, 2025.